Pfizer Signs Marketing and Supply Deal with Mylan Pharmaceuticals
Under the terms of the agreement, Pfizer will retain ownership of the brands, while Mylan will be responsible for their marketing and sales within India for a period of five years.
Ativan | 25/02/2025 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy